España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Nutriband
NTRBW
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.01
-0.24
-10.67%
At close: -
$1.49
-0.52
-25.87%
After Hours: Jan 22, 7:43 AM EDT
Get Report
Comment
Nutriband (NTRBW) Forecast
News
Earnings
Nutriband (NTRBW) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nutriband (NASDAQ:NTRBW) Stock
Nutriband Stock (NASDAQ: NTRBW)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 05, 2024
Nutriband Signs Commercial Development And Cl...
Benzinga Newsdesk
Friday, July 14, 2023
Nutriband Increases Existing Credit Line To $5M Supporting The Continued Development Of Its AVERSA Platform Towards FDA Submission
Happy Mohamed
Friday, June 23, 2023
Nutriband Receives Notice of Allowance for U....
Benzinga Newsdesk
Tuesday, March 28, 2023
Nutriband Secured $2M Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Charles Gross
Wednesday, February 15, 2023
Nutriband To File for Product Distribution Permit In South America With Ecuador's Health Register
Charles Gross
Friday, December 30, 2022
Nutriband Inc. To Dual List On Upstream
Benzinga Newsdesk
Thursday, December 01, 2022
Nutriband Receives Notice Of Issuance From Th...
Benzinga Newsdesk
Thursday, October 27, 2022
Nutriband To Manufacture Fleur Marché-Branded CBD Wellness Patches
Vuk Zdinjak
Nutriband Inc. To Manufacture Fleur Marché-Br...
Benzinga Newsdesk
Wednesday, October 26, 2022
Nutriband Subsidiary, 4P Therapeutics LLC, Co...
Benzinga Newsdesk
Tuesday, October 04, 2022
Nutriband And Kindeva Highlight Abuse-Deterrent Characteristics For AVERSA
Bill Haddad
Monday, August 01, 2022
Nutriband Receives Notice Of Allowance From T...
Benzinga Newsdesk
Wednesday, July 27, 2022
Nutriband Inc. Announces Seven-For-Six Forward Stock Split, Effective Aug. 15
Bill Haddad
Tuesday, July 26, 2022
Nutriband Announced 1.2M Shares to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
Charles Gross
Tuesday, May 17, 2022
Nutriband Inc. Receives Orders For $230,000 In Contract Manufacturing For First 3 Weeks Of May
Bill Haddad
Wednesday, May 11, 2022
Nutriband Subsidiary Active Intelligence LLC Registers With FDA As A Medical Device Manufacturer For Its AI Kinesiology Tape Product
Bill Haddad
Wednesday, February 16, 2022
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System' Published By United States Patent And Trademark Office Following Recent Issuance Notice
Bill Haddad
Tuesday, January 18, 2022
Nutriband Announces Expanded Pipeline For AVERSA Abuse Deterrent Technology
Bill Haddad
Tuesday, December 21, 2021
Nutriband Inc. Initiates Plans To Offer Topical Lotion Contract Manufacturing Services
Bill Haddad
Tuesday, October 12, 2021
Nutriband Inc. Signs Exclusive Manufacturing Agreement For Diocheck Visual COVID-19 Antibody Indicator Patch
Bill Haddad
Friday, October 01, 2021
Nutriband Priced $6.6M Public Offering At $6....
Benzinga Newsdesk
